Test Code PR3AB Proteinase-3 Ab
Additional Codes
Meditech Order: PR3AB
Panel Order: VASCPANEL
Intended Use
EliA PR3S is intended for the in vitro semi-quantitative measurement of IgG antibodies directed to proteinase 3 (PR3) in human serum and plasma (Li-heparin, EDTA) as an aid in the clinical diagnosis of Granulomatosis with Polyangiitis (GPA, formerly called Wegener's Granulomatosis) in conjunction with other laboratory and clinical findings. EliA PR3S uses the EliA IgG method on the instrument Phadia 250.
Performing Lab
Boone Health Laboratory
Collection Method
Venous Collection
Container
Gold Serum Tube
Instructions/Special Handling
None
Preferred Specimen
Gold SST Serum Tube
Red Serum
Acceptable Specimes
- Plasma
- Lithium Heparin
- EDTA
Units
| EliA U/mL |
Reference Ranges
| <2.0 | Negative |
| >3.0 | Positive |
| 2.0-3.0 | Equivoval (recommend retesting after 8-12 weeks) |
| >160 | >160 EliA U/mL |
Critical Values
N/A
Reasons for Rejection
| Hemolysis | Grossly hemolyzed (>494 mg/dl) |
| Icterus | Bilirubin >19.1mg/dl |
| Lipemia | >1000 |
| Other | Contaminated specimen, Rheumatoid factor IgM (550 IU/mL),QNS, Improperly labeled, Improper specimen type |
Specimen Stability
| Ambient (15-25°C) | 8 hours |
| Refrigerated (2-8°C) | 14 days |
| Frozen (-20°C) | 12months (only one freeze thaw cycle) |
Performance Information
| Days/Times Performed | Monday, Wednesday and Friday |
| Expected Turn around Time | 1-3 days |
| Methodology/Method Description | EliA IgG |
CPT Code(s)
86036